December 23, 2025 a 01:00 pm
MRNA: Fundamental Ratio Analysis - Moderna, Inc.
Moderna, Inc., a pivotal player in biotechnology, focuses on mRNA therapeutics and vaccines, addressing areas ranging from infectious to rare diseases. Despite its groundbreaking work, MRNA's stock exhibits moderate performance indicators. Investors should consider both the potential breakthrough innovations and the associated risks in this volatile industry.
Fundamentals Rating
Moderna's fundamentals demonstrate moderate potential with room for improvement across various financial metrics.
| Category | Score | Visualization |
|---|---|---|
| Discounted Cash Flow | 3 | |
| Return On Equity | 1 | |
| Return On Assets | 1 | |
| Debt To Equity | 3 | |
| Price To Earnings | 1 | |
| Price To Book | 4 |
Historical Rating
The historical rating highlights a consistent performance with minor changes, reflecting stable yet unspectacular growth.
| Date | Overall Score | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|
| 2025-12-22 | 2 | 3 | 1 | 1 | 3 | 1 | 4 |
| 2025-12-23 | 2 | 3 | 1 | 1 | 3 | 1 | 4 |
Analyst Price Targets
Analysts project varied price targets, indicating uncertainty about Moderna's future prospects.
| High | Low | Median | Consensus |
|---|---|---|---|
| 63 | 15 | 28 | 29.27 |
Analyst Sentiment
The analyst sentiment reflects a predominant hold recommendation, signifying cautious optimism in the stock's future.
| Recommendation | Count | Visualization |
|---|---|---|
| Strong Buy | 0 | |
| Buy | 9 | |
| Hold | 14 | |
| Sell | 4 | |
| Strong Sell | 0 |
Conclusion
Moderna, Inc. presents a complex investment opportunity with its leading-edge biotechnology ventures. While the fundamentals indicate room for growth, potential investors should weigh the inherent risks associated with the biotech industry. Market sentiment is predominantly neutral, urging a cautious approach. The diverse analyst predictions suggest a volatile future performance. Consider both innovative potential and market dynamics before making investment decisions.